Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bora Gurel

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsTamara L Lotan, Bora Gurel, Siobhan Sutcliffe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavityMichael C Haffner, Johannes Laimer, Alcides Chaux, et al.
Nutrition and Cancer|January 29, 2021
Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention TrialSusan Chadid, Xiaoling Song, Jeannette M Schenk, et al.
Cancer Research|November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneitySrinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate CancerBeshara Sheehan, Antje Neeb, Lorenzo Buroni, et al.
The American Journal of Pathology|March 26, 2011
Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogeneCheryl M Koh, Bora Gurel, Siobhan Sutcliffe, et al.
Nature Genetics|July 6, 2010
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangementsMichael C Haffner, Martin J Aryee, Antoun Toubaji, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Cancer Treatment and Research Communications|February 7, 2021
Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation - a Single Unit ExperienceAndrea Biondo, Abhijit Pal, Ruth Riisnaes, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
The Prostate|June 8, 2020
The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention TrialSusan Chadid, John R Barber, William G Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsTamara L Lotan, Bora Gurel, Siobhan Sutcliffe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavityMichael C Haffner, Johannes Laimer, Alcides Chaux, et al.
Nutrition and Cancer|January 29, 2021
Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention TrialSusan Chadid, Xiaoling Song, Jeannette M Schenk, et al.
Cancer Research|November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneitySrinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate CancerBeshara Sheehan, Antje Neeb, Lorenzo Buroni, et al.
The American Journal of Pathology|March 26, 2011
Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogeneCheryl M Koh, Bora Gurel, Siobhan Sutcliffe, et al.
Nature Genetics|July 6, 2010
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangementsMichael C Haffner, Martin J Aryee, Antoun Toubaji, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Cancer Treatment and Research Communications|February 7, 2021
Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation - a Single Unit ExperienceAndrea Biondo, Abhijit Pal, Ruth Riisnaes, et al.
Pageof 8